News

News
In the media

Mestag Therapeutics

Read full story
JNJ Press releases

LAVA THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS SECOND QUARTER RESULTS

Read full story
JNJ Press releases

New report reveals strength of the UK’s thriving genomics sector

Read full story
JNJ Press releases

MESTAG THERAPEUTICS EXTENDS SEED FINANCING TO $45 MILLION AND WELCOMES NEW INVESTORS FORBION, GV (FORMERLY GOOGLE VENTURES) AND NORTHPOND VENTURES

Read full story
In the media

Johnson & Johnson: The Leading Healthcare Group at the Forefront of Open Innovation

Read full story
In the media

Michael Hübner – New Venture Lead, Johnson & Johnson Innovation Switzerland

Read full story
In the media

Inside Johnson & Johnson’s Nonstop Hunt for a Coronavirus Vaccine

Read full story
In the media

Investing in innovation – new digital approaches for a new decade

Read full story
In the media

BIO: Is COVID-19 changing how biopharmas think of M&A? Not really, say J&J and Takeda execs

Read full story
In the media

As Biotech drifts from amyloid hypothesis for Alzheimer’s some see reason to cling on

Read full story
In the media

The Startup Slam, a Highlight at BIO-Europe 2019

Read full story
In the media

At the Bio-Europe conference in Hamburg last month, experts weighed in on the challenges and future of neuroscience

Read full story
In the media

Medopad And Janssen Develop Automated Digital Test To Detect Alzheimer’s Earlier

Read full story
In the media

Winners Announced For The UK and Ireland's Top Science Journalism Awards

Read full story
In the media

Science City Meet the Media in London

Read full story